Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

Links shared publicly online about this topic.

1,106
total visits

Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians.

View full resource at news-medical.net

Tags: Cancer, Ovarian Cancer, Lab Test, Women's Health, Physician